Page last updated: 2024-10-23

benzothiazide and Hemochromatosis

benzothiazide has been researched along with Hemochromatosis in 1 studies

benzothiazide: structure
benzthiazide : 7-Sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by chlorine and that at position 3 is substituted by a benzylsulfanylmethyl group. A diuretic, it is used to treat hypertension and edema.

Hemochromatosis: A disorder of iron metabolism characterized by a triad of HEMOSIDEROSIS; LIVER CIRRHOSIS; and DIABETES MELLITUS. It is caused by massive iron deposits in parenchymal cells that may develop after a prolonged increase of iron absorption. (Jablonski's Dictionary of Syndromes & Eponymic Diseases, 2d ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MIROUZE, J1
JAFFIOL, C1

Other Studies

1 other study available for benzothiazide and Hemochromatosis

ArticleYear
[IMPORTANCE OF BENZTHIAZIDE, AN ORIGINAL SULFONAMIDE DIURETIC].
    Gazette medicale de France, 1963, Sep-25, Volume: 70

    Topics: Benzothiadiazines; Diabetes Mellitus; Diuretics; Edema; Hemochromatosis; Hypertension; Kidney Diseas

1963